What is Thrive Bioscience?
Thrive Bioscience specializes in automated live cell imaging solutions, providing researchers with advanced tools for quantitative biology. Their flagship products include the Thrive IQ software platform and the CellAssist family of imaging systems, which facilitate the collection and analysis of multidimensional data on live cells, colonies, and organoids. The company aims to empower biologists and data scientists by transforming cell behavior into AI-ready data sets, enhancing experimental efficiency and reproducibility. Thrive Bioscience serves clients in the biotechnology and pharmaceutical sectors, focusing on improving computational models and bioprocessing workflows.
How much funding has Thrive Bioscience raised?
Thrive Bioscience has raised a total of $18.9M across 7 funding rounds:
Multiple Rounds
$9.4M
Private Equity
$7.2M
Debt
$1.8M
Debt
$150K
Debt
$319K
Angel/Seed (2015): $3.3M, investors not publicly disclosed
Angel/Seed (2015): $4M, investors not publicly disclosed
Debt (2015): $2.2M, investors not publicly disclosed
Private Equity (2016): $7.2M, investors not publicly disclosed
Debt (2017): $1.8M, investors not publicly disclosed
Debt (2020): $150K with participation from PPP
Debt (2021): $319K led by PPP
Key Investors in Thrive Bioscience
PPP
Public-Private Partnership
What's next for Thrive Bioscience?
With a substantial enterprise-level funding context and a recent strategic investment, Thrive Bioscience is poised for accelerated growth. The company's focus on generating AI-ready data from live cell imaging positions it at the intersection of biology, data science, and artificial intelligence. Future endeavors will likely involve expanding their product offerings, enhancing their AI capabilities for deeper biological insights, and broadening their market reach within the pharmaceutical and biotechnology industries. This strategic capital infusion is expected to fuel innovation in computational biology and bioprocessing, further solidifying Thrive Bioscience's position as a key player in quantitative biology research.
See full Thrive Bioscience company page
